ARCHIVES

Drugs Available To Investigators Centers to Monitor Them Are Listed

This article is from The Cancer Letter archive.

Vol. 03 No. 36 | September 9, 1977

Download PDF Visit The Full Archive

Related Articles

High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer

January 25, 2008

Cancer Policy; Board Suggests More Detailed Items In Tobacco Agreement

August 22, 1997

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

April 4, 1980

Taxotere Added To Regimen Improves Survival, Study Finds

July 29, 2005

NCCN Updates Treatment Guidelines To Include CEF For Early Breast Cancer.

January 26, 2001

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

August 4, 1995